Citation Tools
PDFRegular Abstracts – Part 2
Checkpoint Blockade Therapy
579-A Targeting the NANOG-CRY1 axis sensitizes immunotherapy-refractory tumors and enhances efficacy of T cell-based immunotherapy by reinvigorating the anti-tumor immunity cycle
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 579-A Targeting the NANOG-CRY1 axis sensitizes immunotherapy-refractory tumors and enhances efficacy of T cell-based immunotherapy by reinvigorating the anti-tumor immunity cycle